The 4th Rare Cancers Symposium, hosted by TRACER at Fred Hutch in Seattle, brought together leading researchers, clinicians and advocates to share progress in immunotherapy, biobanking, and clinical trial design for rare cancers. From patient-driven initiatives to cutting-edge diagnostics, the event underscored the power of collaboration in tackling rare diseases.
Read the full story here:
Gujral Lab, Fred Hutch
Deanna works directly with rare tumor samples donated by patients. Her work helps make the most of each precious sample by supporting tumor profiling, functional testing, and data generation that can help accelerate rare cancer research.
Uterine Mesenchymal Tumors Alliance (UMTA) connects patients, clinicians, pathologists and researchers to improve care for those affected by uterine mesenchymal tumors.